HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vincent A Miller Selected Research
Vincent A Miller Research Topics
Disease
179
Neoplasms (Cancer)
10/2021 - 02/2002
68
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2002
44
Lung Neoplasms (Lung Cancer)
12/2020 - 01/2005
34
Adenocarcinoma of Lung
01/2018 - 01/2005
22
Adenocarcinoma
01/2021 - 03/2004
20
Carcinoma (Carcinomatosis)
01/2020 - 07/2002
19
Breast Neoplasms (Breast Cancer)
11/2020 - 02/2002
15
Neoplasm Metastasis (Metastasis)
03/2021 - 11/2002
14
Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 06/2003
9
Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
7
Microsatellite Instability
01/2020 - 11/2016
7
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 02/2011
7
Disease Progression
02/2016 - 05/2005
6
Exanthema (Rash)
01/2022 - 09/2005
6
Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2012
5
Diarrhea
01/2022 - 09/2005
5
Triple Negative Breast Neoplasms
02/2019 - 02/2014
5
Fatigue
11/2017 - 05/2005
4
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 02/2003
4
Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 08/2015
4
Squamous Cell Carcinoma of Head and Neck
10/2019 - 01/2013
3
Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2017
3
Hematologic Neoplasms (Hematological Malignancy)
12/2018 - 01/2016
3
Hypersensitivity (Allergy)
01/2018 - 02/2008
3
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2017 - 05/2005
3
Inflammatory Breast Neoplasms
11/2015 - 02/2014
3
Colonic Neoplasms (Colon Cancer)
01/2015 - 07/2012
3
Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
05/2011 - 11/2004
3
Stomatitis
08/2007 - 06/2003
2
Glioma (Gliomas)
01/2020 - 11/2016
2
Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 12/2015
2
Testicular Neoplasms (Testicular Cancer)
01/2020 - 01/2019
2
Lymphoma (Lymphomas)
01/2018 - 10/2011
Drug/Important Bio-Agent (IBA)
58
ErbB Receptors (EGF Receptor)
IBA
01/2018 - 06/2003
42
Tyrosine Kinase Inhibitors
IBA
01/2021 - 02/2003
40
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2017 - 01/2005
39
Gefitinib (Iressa)
FDA Link
01/2022 - 06/2003
38
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 11/2008
30
Phosphotransferases (Kinase)
IBA
01/2020 - 01/2005
27
Biomarkers (Surrogate Marker)
IBA
12/2020 - 03/2011
18
Formaldehyde (Formol)
FDA Link
01/2020 - 05/2013
18
Paraffin
IBA
01/2020 - 05/2013
17
Crizotinib
IBA
10/2019 - 09/2012
17
Proteins (Proteins, Gene)
FDA Link
01/2019 - 02/2002
16
Immune Checkpoint Inhibitors
IBA
10/2021 - 03/2016
12
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2019 - 11/2003
12
Anaplastic Lymphoma Kinase
IBA
01/2018 - 12/2012
10
Circulating Tumor DNA
IBA
10/2020 - 01/2017
10
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2019 - 04/2010
9
Everolimus
FDA Link
01/2021 - 08/2007
9
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2020 - 01/2016
8
RNA (Ribonucleic Acid)
IBA
01/2020 - 12/2013
8
Afatinib
IBA
11/2017 - 05/2012
8
Paclitaxel (Taxol)
FDA Link
Generic
06/2012 - 06/2003
7
Estrogen Receptors
IBA
11/2020 - 12/2013
7
TOR Serine-Threonine Kinases
IBA
09/2017 - 10/2010
6
Docetaxel (Taxotere)
FDA Link
07/2007 - 02/2003
5
Trastuzumab (Herceptin)
FDA Link
11/2019 - 02/2002
5
Ligands
IBA
12/2018 - 07/2012
4
tyrosine receptor (receptor, tyrosine)
IBA
01/2020 - 01/2012
4
Monoclonal Antibodies
IBA
12/2019 - 02/2002
4
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
11/2019 - 05/2014
4
MTOR Inhibitors
IBA
01/2019 - 01/2013
4
dabrafenib
IBA
01/2018 - 01/2015
4
Cetuximab (Erbitux)
FDA Link
11/2017 - 04/2011
4
Mitogen-Activated Protein Kinases
IBA
11/2016 - 04/2010
4
Carboplatin (JM8)
FDA Link
Generic
06/2012 - 06/2003
3
Albumins
IBA
03/2021 - 02/2008
3
Platinum
IBA
12/2020 - 07/2010
3
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2020 - 05/2014
3
Solvents
IBA
12/2019 - 11/2011
3
Codon (Codons)
IBA
12/2019 - 09/2008
3
osimertinib
IBA
12/2019 - 01/2017
3
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2019 - 05/2014
3
Cytotoxins (Cytolysins)
IBA
01/2019 - 09/2003
3
Calcibiotic Root Canal Sealer
IBA
01/2018 - 01/2016
3
trametinib
IBA
01/2018 - 01/2015
3
Proto-Oncogene Proteins c-met
IBA
01/2017 - 01/2016
3
Sorafenib (BAY 43-9006)
FDA Link
10/2016 - 01/2014
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2016 - 08/2007
3
alectinib
IBA
01/2016 - 12/2014
3
Threonine (L-Threonine)
FDA Link
11/2008 - 03/2005
2
palbociclib
IBA
11/2020 - 01/2017
2
HM781-36B
IBA
03/2020 - 10/2019
2
Tumor Biomarkers (Tumor Markers)
IBA
12/2019 - 11/2004
2
Estrogen Receptor Modulators (Antiestrogen)
IBA
01/2019 - 08/2017
2
Heme (Haem)
IBA
12/2018 - 01/2018
2
Cell-Free Nucleic Acids
IBA
11/2018 - 01/2018
2
Cyclin-Dependent Kinase Inhibitor p15
IBA
10/2018 - 11/2016
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
10/2018 - 11/2016
2
temsirolimus
FDA Link
01/2018 - 01/2014
2
Sirolimus (Rapamycin)
FDA Link
01/2018 - 11/2016
Therapy/Procedure
110
Therapeutics
01/2022 - 03/2005
40
Drug Therapy (Chemotherapy)
12/2020 - 02/2002
10
Immunotherapy
01/2021 - 09/2004
7
Ligation
01/2017 - 01/2014
5
Radiotherapy
01/2017 - 07/2002
4
Precision Medicine
03/2021 - 05/2014
3
Aftercare (After-Treatment)
01/2017 - 03/2008
3
Neoadjuvant Therapy
03/2016 - 02/2014